The anti-AD multi-target prediction platform showed that 3,4-Dimethoxycinnamic acid might act on ACHE, APP, PTGS2, GSK3B, which provides a reference for the further study of this chemical constituent. This evidence concerns the gene ACHE and Alzheimer disease.